Calcium Chloride → (1-ethyl-3-{4-[(3-methyl-3H-imidazo[4,5-b]pyridin-2-yl)oxy]phenyl}-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yl)methyl acetate
反応式
[CH3:1][N:2]1[C:6]2=[N:7][CH:8]=[CH:9][CH:10]=[C:5]2[N:4]=[C:3]1S(C)(=O)=O.[C:15]([O:18][CH2:19][C:20]1[CH:25]=[CH:24][N:23]=[C:22]2[N:26]([C:32]3[CH:37]=[CH:36][C:35]([OH:38])=[CH:34][CH:33]=3)[C:27](=[O:31])[N:28]([CH2:29][CH3:30])[C:21]=12)(=[O:17])[CH3:16].CC(C)([O-])C.[K+].[Cl-].[Cl-].[Ca+2]>CC(N(C)C)=O>[C:15]([O:18][CH2:19][C:20]1[CH:25]=[CH:24][N:23]=[C:22]2[N:26]([C:32]3[CH:33]=[CH:34][C:35]([O:38][C:3]4[N:2]([CH3:1])[C:6]5=[N:7][CH:8]=[CH:9][CH:10]=[C:5]5[N:4]=4)=[CH:36][CH:37]=3)[C:27](=[O:31])[N:28]([CH2:29][CH3:30])[C:21]=12)(=[O:17])[CH3:16]参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
3-Methyl-2-(methylsulfonyl)-3H-imidazo[4,5-b]pyridine (110 mg) was added to a solution of [1-ethyl-3-(4-hydroxyphenyl)-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yl]methyl acetate (170 mg) and potassium tert-butoxide (69.9 mg) in DMA (1 mL) at room temperature. The mixture was stirred at 100° C. under a dry atmosphere (CaCl2 tube) for 30 min. The reaction mixture was concentrated in vacuo. The residue was purified by column chromatography (NH silica gel, eluted with 0%-100% EtOAc in hexane) to give (1-ethyl-3-{4-[(3-methyl-3H-imidazo[4,5-b]pyridin-2-yl)oxy]phenyl}-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yl)methyl acetate (10 mg) as colorless crystals.
後処理
- concentrationThe reaction mixture was concentrated in vacuo
- customThe residue was purified by column chromatography (NH silica gel, eluted with 0%-100% EtOAc in hexane)
出典と根拠
- ORDレコード
- ord-1e67981dd2d94c7597b3cc8aff0a8747
- 出典データセット
- uspto-grants-2015_01
- 特許番号
- US08940758B2
反応ノート
読み込み中…